ATLANTA, Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading cardiac and vascular surgery company focused
on aortic disease, announced today that it will participate in two
upcoming virtual investor conferences.
CryoLife's management team will present at the upcoming
Canaccord Genuity 41st Annual Growth Conference on
Wednesday, August 11, 2021. The
Company's presentation is scheduled to begin at 9:30 a.m. ET. A live webcast of the presentation
will be accessible through CryoLife's website, www.cryolife.com, on
the Investor Relations page. An archived copy of the webcast will
be available for 90 days on the same website.
Members of the management team will also participate in the
6th Annual Needham Virtual Med Tech 1x1 Conference on
Monday, August 16, 2021 &
Tuesday, August 17, 2021. Due to the
format of this event no webcast will be available.
About CryoLife, Inc.
Headquartered in suburban
Atlanta, Georgia, CryoLife is a
leader in the manufacturing, processing, and distribution of
medical devices and implantable tissues used in cardiac and
vascular surgical procedures focused on aortic repair. CryoLife
markets and sells products in more than 100 countries worldwide.
For additional information about CryoLife, visit our website,
www.cryolife.com.
|
Contacts:
|
|
|
|
|
CryoLife
D. Ashley
Lee
Executive Vice
President, Chief Financial Officer
and Chief Operating
Officer
Phone: 770-419-3355
|
Gilmartin Group
LLC
Brian Johnston / Lynn
Lewis
Phone:
631-807-1986
investors@cryolife.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cryolife-to-participate-in-upcoming-virtual-investor-conferences-301346282.html
SOURCE CryoLife, Inc.